Eye Health Advancements and Ongoing Challenges in Africa

By Crystal Lubbe

October 15, 2024

The article titled “Promising progress on eye health in the African region, but challenges remain” from the World Health Organization (WHO) Regional Office for Africa highlights several key points regarding the current state of eye health in the African region. While there has been notable progress in eye health, significant challenges remain that hinder further advancements.

Progress Made

Despite significant challenges, progress has been made in integrating eye health into primary health care services in African countries. The WHO has recorded a decrease in vision loss due to Vitamin A deficiency, onchocerciasis, and trachoma. These gains are critical for improving overall well-being and reducing the economic burden associated with preventable vision loss.

Challenges

A dire shortage of financial resources and the concentration of scarce human resources in urban areas continue to hinder eye health progress. This results in low community awareness and inadequate access to eye care services. Only 14% of people who need cataract surgery receive it, while more than 80% of those with shortsightedness do not receive treatment. This is in stark contrast to other regions like North America, Australasia, Western Europe, and the Asia-Pacific, where the figures are lower than 10%. The global estimated costs of uncorrected refractive errors and cataracts are significant, amounting to US$14.3 billion annually.

Emerging Challenges

There is a rising trend of eye health challenges related to aging populations, unhealthy lifestyles, and noncommunicable diseases such as diabetic retinopathy and age-related macular degeneration.

WHO’s Current Focus and Initiatives

The WHO is actively supporting countries to integrate eye health services at the primary care level as part of universal health coverage. This includes providing technical support to countries like Ethiopia, Ghana, Niger, Nigeria, Somalia, and Zambia through national situational analyses, strategic plans, and monitoring frameworks. The SPECS 2030 initiative aims to increase the number of people with access to appropriate spectacles, targeting an effective coverage of refractive error (eREC) of 40% by 2030. Liberia and Mozambique have begun implementing this initiative. Furthermore, the WHO has launched a free self-assessment tool called WHOeyes to promote healthy habits and raise eye care awareness. This tool is available in multiple languages and helps check visual acuity while providing educational messaging.

Economic and Social Impact

Good vision significantly impacts overall well-being, academic achievements, and economic growth. Therefore, addressing eye health challenges is crucial for broader societal benefits.

In summary, while there has been progress in reducing certain causes of blindness in Africa, significant challenges persist, including financial and human resource constraints, low community awareness, and emerging eye health issues related to noncommunicable diseases. The WHO is committed to addressing these challenges through various initiatives and support programs aimed at improving eye health in the African region.

Reference url

Recent Posts

EU Life Sciences Strategy
         

EU Life Sciences Strategy: Paving the Way for Europe’s Leadership by 2030

🚀 Is Europe poised to reclaim its leadership in life sciences by 2030?

The European Commission has unveiled a game-changing strategy aimed at transforming the EU into the world’s leading hub for life sciences, tackling critical challenges in health, biotechnology, and sustainability. With strategic investments and reforms, this initiative promises to bridge the innovation gap and enhance public health outcomes across the continent.

Curious about how these plans will impact the life sciences landscape? Explore the full insights of this exciting strategy!

#SyenzaNews #HealthcareInnovation #DigitalTransformation #Innovation

ticagrelor data integrity
          

Ticagrelor Data Integrity Under Fire: Scrutiny Reveals Flaws in Key Clinical Trials

🔍 Are we truly getting the full story on high-cost medications like ticagrelor?

A recent BMJ investigation has raised alarm bells over the integrity of data from pivotal studies on AstraZeneca’s ticagrelor, revealing significant misreporting and missing data that may undermine its clinical benefits. This exposes critical implications for health economics, regulatory oversight, and market access.

Curious about how these findings could reshape perceptions of drug efficacy and safety? Dive into the full article to uncover the truth behind the numbers.

#SyenzaNews #HealthEconomics #Pharmaceuticals #MarketAccess

self-care public health
    

The Value of Self-Care in Public Health: Insights and Implications for Europe

🌍 Are we overlooking the power of self-care in Europe’s public health strategy?

The rise of self-care public health is reshaping how minor ailments are managed across the continent, leading to remarkable economic and productivity benefits. With annual savings of €36 billion and lifestyle improvements for consumers, self-care is proving to be a game-changer for healthcare systems.

Explore how embracing self-care can alleviate pressure on healthcare providers and enhance individual well-being. Dive into the full article to discover the implications for health economics and public policy!

#SyenzaNews #HealthEconomics #HealthcarePolicy

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER

© 2025 Syenza™. All rights reserved.